Boehringer Ingelheim gets an IBD bispecific from Shanghai-based Simcere
Boehringer Ingelheim gets an IBD bispecific from Shanghai-based Simcere
Boehringer Ingelheim gets an IBD bispecific from Shanghai-based Simcere
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.